Alexium continues to see forward momentum in both revenue and gross profit from increased order volume with existing customers and new customers coming on line. Chemistry sales grew over 1000% to $11,193,372 for the period, an increase from $973,121 from the previous half year report, from core product sales. The group’s net loss for the period, $5,806,993, down from $9,008,753 for the half-year ended 31 December 2015, is related to increased sales revenue and improved margins on customer orders.
Alexium continues to see forward momentum in both revenue and...
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.935M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2784038 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 303203 | 2 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable